Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography
Molly Flexman(Columbia University), Andreas H. Hielscher(Columbia University Irving Medical Center), Emerson A. Lim(Columbia University), Maria Alvarez(Columbia University Irving Medical Center), Hyun Koo Kim(Columbia University Irving Medical Center), Jacqueline Gunther(Columbia University), Kevin Kalinsky(Emory University), Dawn L. Hershman(American Society of Clinical Oncology), Elise Desperito(Columbia University Irving Medical Center)
Cited by 70
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991
American Society of Clinical Oncology Position Statement on Obesity and Cancer
|Journal of Clinical Oncology|2014|524
Current Landscape of Immunotherapy in Breast Cancer
|JAMA Oncology|2019|409
AKT in cancer: new molecular insights and advances in drug development
|British Journal of Clinical Pharmacology|2016|267